Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Jayasree Pillarisetti"'
Autor:
Jayasree Pillarisetti, Mubeen S. Cheema, Justin Haloot, Manoj Panday, Auroa Badin, Anjlee Mehta, Allen S. Anderson, Anand Prasad
Publikováno v:
Indian Heart Journal, Vol 74, Iss 3, Pp 170-177 (2022)
Background: Coronavirus disease-2019 (COVID-19) has been associated with pre-existing cardiac conditions as well as cardiovascular complications. The incidence rates of cardiac complications, age, and gender differences in this population are unknown
Externí odkaz:
https://doaj.org/article/28102ea3d6de4b148bd58198619eb8d0
Autor:
Ariel Vinas, MD, Debanshu Roy, MD, Cynthia Saunders, ANP, Auroa Badin, MD, Manoj M. Panday, MD, Jayasree Pillarisetti, MD
Publikováno v:
JACC: Case Reports, Vol 3, Iss 2, Pp 322-326 (2021)
The American College of Cardiology/American Heart Association guidelines recommend a wearable cardioverter defibrillator (WCD) for certain conditions or scenarios. WCD is felt to provide adequate protection against ventricular arrhythmias. This case
Externí odkaz:
https://doaj.org/article/a62a9181b4d844a5a8732e5e0cab627e
Autor:
Jayasree Pillarisetti, Madhu Reddy, Mamatha Vodapally, Tulasi Annapureddy, Maruthsakhi Molugu, Donita Atkins, Sudharani Bommana, Rhea Pimentel, Raghuveer Dendi, Dhanunjaya Lakkireddy
Publikováno v:
Indian Pacing and Electrophysiology Journal, Vol 20, Iss 6, Pp 261-264 (2020)
Introduction: Prospective studies on rivaroxaban and apixaban have shown the safety and efficacy of direct anticoagulation agents (DOAC)s used peri-procedurally during radiofrequency ablation (RFA) of atrial fibrillation (AF). Studies comparing the t
Externí odkaz:
https://doaj.org/article/7d1068bab5004f549dcd4ab0c5b474d3
Autor:
Jayasree Pillarisetti, MD, Martin Emert, MD, Mazda Biria, MD, Rashaad Chotia, MD, Rajeshwer Guda, MBBS, Sudharani Bommana, M.Phil, Rhea Pimentel, MD, James Vacek, MD, MSc, FACC, FAHA, Raghuveer Dendi, MD, Loren Berenbom, MD, Buddhadeb Dawn, MD, FAHA, Dhanunjaya Lakkireddy, MD, FACC, FHRS
Publikováno v:
Indian Pacing and Electrophysiology Journal, Vol 15, Iss 1, Pp 20-29 (2015)
Background: Despite ACC/AHA guidelines indicating implantable cardioverter defibrillator (ICD) as class I therapy for primary prevention of sudden cardiac death in patients with EF≤35%, ICD utilization rates in real world practice have been low. Ob
Externí odkaz:
https://doaj.org/article/adf61dbc24724cac8d0e7853d39f3870
Publikováno v:
Indian Pacing and Electrophysiology Journal, Vol 9, Iss 1, Pp 60-63 (2009)
We report a patient with an implantable cardioverter defibrillator (ICD) for arrhythmogenic right ventricular dysplasia (ARVD) who received inappropriate shocks for atrioventricular node reentry tachycardia (AVRNT). Patient had multiple shocks for ta
Externí odkaz:
https://doaj.org/article/88417c350c5a43aeaf84f0190b9c5bd4
Autor:
Jonathan H. Whiteson, Alba Azola, John T. Barry, Matthew N. Bartels, Svetlana Blitshteyn, Talya K. Fleming, Mark D. McCauley, Jacqueline D. Neal, Jayasree Pillarisetti, Sarah Sampsel, Julie K. Silver, Carmen M. Terzic, Jenna Tosto, Monica Verduzco‐Gutierrez, David Putrino
Publikováno v:
PM&R. 14:855-878
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebae1d681062499326821a2396bcbb03
https://doi.org/10.1002/pmrj.12859
https://doi.org/10.1002/pmrj.12859
Publikováno v:
Physical Medicine and Rehabilitation Clinics of North America.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::527374b7c6478f8f43212c34cb5675c6
https://doi.org/10.1016/j.pmr.2023.04.003
https://doi.org/10.1016/j.pmr.2023.04.003
Autor:
Kamala P, Tamirisa, Uri, Elkayam, Joan E, Briller, Pamela K, Mason, Jayasree, Pillarisetti, Faisal M, Merchant, Hena, Patel, Dhanunjaya R, Lakkireddy, Andrea M, Russo, Annabelle Santos, Volgman, Marmar, Vaseghi
Publikováno v:
JACC: Clinical Electrophysiology. 8:120-135
Increasing maternal mortality and incidence of arrhythmias in pregnancy have been noted over the past 2 decades in the United States. Pregnancy is associated with a greater risk of arrhythmias, and patients with a history of arrhythmias are at signif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437d6b854298a2f983ede91a2c7562fc
https://doi.org/10.1016/j.jacep.2021.10.004
https://doi.org/10.1016/j.jacep.2021.10.004
Autor:
Justin Haloot, Aditi Shankar, Supraja Thunuguntla, Hemal M. Nayak, Ratna Bhavaraju-Sanka, Monica Verduzco-Gutierrez, Jayasree Pillarisetti
Publikováno v:
Heart Rhythm. 20:S673
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49e939db4e9f6e99963248191127b3dc
https://doi.org/10.1016/j.hrthm.2023.03.1404
https://doi.org/10.1016/j.hrthm.2023.03.1404
Autor:
Auroa Badin, Cynthia Saunders, Manoj M. Panday, Debanshu Roy, Jayasree Pillarisetti, Ariel Vinas
Publikováno v:
JACC Case Reports
JACC: Case Reports, Vol 3, Iss 2, Pp 322-326 (2021)
JACC: Case Reports, Vol 3, Iss 2, Pp 322-326 (2021)
The American College of Cardiology/American Heart Association guidelines recommend a wearable cardioverter defibrillator (WCD) for certain conditions or scenarios. WCD is felt to provide adequate protection against ventricular arrhythmias. This case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b298e04f7040811a66885194f8c96de4
http://europepmc.org/articles/PMC8310987
http://europepmc.org/articles/PMC8310987